Anticoagulation strategies for the management of postoperative atrial fibrillation.

Published

Other Article (Review)

Patients undergoing thoracic and cardiac procedures are at the highest risk for postoperative atrial fibrillation (POAF). POAF is associated with poor short-term and long-term outcomes, including high rates of early and late stroke, and late mortality. Patients with POAF that persists for longer than 48 hours should be anticoagulated on warfarin. Three new oral anticoagulants are available for the treatment of nonvalvular atrial fibrillation and have been found to be as efficacious or superior to warfarin in the prevention of stroke in high-risk patients, with similar to lower rates of major bleeding, and lower rates of intracranial hemorrhage.

Full Text

Duke Authors

Cited Authors

  • Anderson, E; Dyke, C; Levy, JH

Published Date

  • September 2014

Published In

Volume / Issue

  • 34 / 3

Start / End Page

  • 537 - 561

PubMed ID

  • 25168941

Pubmed Central ID

  • 25168941

Electronic International Standard Serial Number (EISSN)

  • 1557-9832

Digital Object Identifier (DOI)

  • 10.1016/j.cll.2014.06.012

Language

  • eng

Conference Location

  • United States